RCS - Intnl. Biotechnology - Latest Factsheet and Blog

International Biotechnology TrustAnnouncement

21/07/2025 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250721:nRSU8645Ra&default-theme=true

RNS Number : 8645R  Intl. Biotechnology Trust PLC  21 July 2025

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

IBT's factsheet for the month ended 30 June 2025 is now available directly via
its web page. Please click here
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
, then 'latest factsheet'.

 

Following up on our recent article, Things are grim, but science will prevail
(https://www.schroders.com/en-gb/uk/individual/content/things-are-grim-but-science-will-prevail/)
, we wanted to provide a further update on what recent political developments
in the US might mean for biotech investors. While many of the details are
still being worked through, two issues - drug pricing reform and potential
tariffs - continue to result in an unusual degree of uncertainty for the
sector. In this note, we explore those concerns in more detail, explain how
they're affecting sentiment, and set out why we believe the long-term
investment case for biotech remains intact.

 

The blog can be read here:

 

https://www.schroders.com/en-gb/uk/individual/content/making-sense-of-a-shifting-policy-landscape/
(https://www.schroders.com/en-gb/uk/individual/content/making-sense-of-a-shifting-policy-landscape/)

 

To sign up for IBT updates by email, please click here
(https://www.schroders.com/en-gb/uk/individual/never-miss-an-update/) .

 

 

ENDS

 

 

Enquiries:

 

 Schroder Investment Management Limited

 Kirsty Preston (PR)                                          020 7658 6000

 Natalia de Sousa                                             020 7658 6000

 Kaso Legg Communications (Financial PR)

                                                              IBT@kl-communications.com (mailto:IBT@kl-communications.com)

 Charles Gorman

 Henry Taylor

 Effie Aye Maung Hider

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAVFLBLEDLEBBV